Evidence map›Paper›PMID 36436107›Full record

ArticleJournal of robotic surgery2023

American Society of Anesthesiologists (ASA) physical status system predicts the risk of postoperative Clavien-Dindo complications greater than one at 90 days after robot-assisted radical prostatectomy: final results of a tertiary referral center.

Antonio Benito Porcaro, Riccardo Rizzetto, Alberto Bianchi, Sebastian Gallina, Emanuele Serafin, Andrea Panunzio, Alessandro Tafuri, Clara Cerrato, Filippo Migliorini, Stefano Zecchini Antoniolli and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Antonio Benito Porcaro *Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani 1, 37126, Verona, Italy. drporcaro@yahoo.com.
Riccardo Rizzetto *Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani 1, 37126, Verona, Italy.
Alberto BianchiDepartment of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani 1, 37126, Verona, Italy.
Sebastian GallinaDepartment of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani 1, 37126, Verona, Italy.
Emanuele SerafinDepartment of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani 1, 37126, Verona, Italy.
Andrea PanunzioDepartment of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani 1, 37126, Verona, Italy.
Alessandro TafuriDepartment of Urology, Vito Fazzi Hospital, 73110, Lecce, Italy.
Clara CerratoDepartment of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani 1, 37126, Verona, Italy.
Filippo MiglioriniDepartment of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani 1, 37126, Verona, Italy.
Stefano Zecchini AntoniolliDepartment of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani 1, 37126, Verona, Italy.
Giovanni NovellaDepartment of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani 1, 37126, Verona, Italy.
Vincenzo De MarcoDepartment of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani 1, 37126, Verona, Italy.
Matteo BrunelliDepartment of Pathology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy.
Salvatore SiracusanoDepartment of Life, Health and Environmental Science, University of L'Aquila, L'Aquila, Italy.
Maria Angela CerrutoDepartment of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani 1, 37126, Verona, Italy.
Enrico PolatiDepartment of Anesthesiology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy.
Alessandro AntonelliDepartment of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani 1, 37126, Verona, Italy.
University of Verona · ITAzienda Ospedaliera Universitaria Integrata Verona · ITOspedale Vito Fazzi · ITUniversity of L'Aquila · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To test the hypothesis of an association between the American Society of Anesthesiologists (ASA) physical status classification system and the risk of 90-days postoperative complications after robot-assisted radical prostatectomy (RARP), graded using the Clavien-Dindo classification system (CDS). In a period ranging from January 2013 to October 2020, 1143 patients were evaluated. ASA classification was computed by trained anesthesiologists. Postoperative complications at 90 days after RARP were grouped as greater than one (CDS between 2 and 4a) versus up to one (CDS between 0 and 1). The risk association was computed using logistic regression models. According to ASA physical status classification system, patients were distributed as follows: 102 (8.9%) ASA 1, 934 (81.7%) ASA 2, and 107 (9.4%) ASA 3. Overall, 90-days postoperative complications occurred in 277 (24.2%) cases, of which 137 (12%) were graded as CDS 1 vs. 105 (9.2%) CDS 2 vs. 17 (1.5%) CDS 3a vs. 15 (1.3%) CDS 3b vs. 3 (0.3%) CDS 4a. ASA 2 and 3 patient categories were more likely to have 90-days postoperative complications CDS > 1 (12.5% and 16.8%, respectively) compared to ASA 1 patients (4.9%). The risk association was stronger for ASA 3 (odds ratio, [OR]: 4.085; 95%CI: 1.457-11.455; p = 0.007) than for ASA 2 (OR: 2.907; 95%CI: 1.106-7.285; p = 0.023) patient categories. After adjustment for clinical, pathological, and perioperative covariates, including pelvic lymph node dissection (performed vs. not performed), either ASA 2 or 3 categories remained independent predictors of 90-days postoperative complications CDS > 1. The risk of 90-days postoperative complications CDS > 1 after RARP increased as the ASA physical status deteriorated independently by performing or not an extended pelvic lymph node dissection. In the ASA 3 patients category, RARP should be performed at tertiary referral centers to safely manage the risk of postoperative complications.

Indexed as

RoboticsRobotic Surgical ProceduresAnesthesiologistsHumansMalePostoperative ComplicationsProstatectomyTertiary Care CentersTreatment OutcomeAmerican Society of Anesthesiologists (ASA) physical status system classificationClavien–Dindo complications systemPostoperative complicationsProstate cancerRadical prostatectomyRobot-assisted radical prostatectomy

Identifiers

PMID36436107
OpenAlexW4310276578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.